Thomson Reuters Stock Quote TRI.PR.B - Stock Price, News, Charts, Message Board, Trades

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Home
Investing
Stocks
Canada
TSX
Thomson Reuters Corp (TRI.PR.B) Quote

Thomson Reuters Corp (TRI.PR.B)

13.89

0.23

( 1.68% )

Updated: 11:03:18

Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Current Price

13.89

Bid

13.65

Ask

13.79

Volume

300

13.89 Day's Range 13.89

0.00 52 Week Range 0.00

Market Cap

Previous Close

13.66

Open

13.89

Last Trade

Last Trade Time

09:30:00

Financial Volume

-

VWAP

-

Average Volume (3m)

-

Shares Outstanding

463,970,000

Dividend Yield

-

PE Ratio

28.20

Earnings Per Share (EPS)

5.81

Revenue

6.79B

Net Profit

2.7B

Sector

Miscellaneous Publishing

Industry

Printing,publishing & Allied

Website

www.thomsonreuters.com

Headquarters

Toronto, Ontario, Can

Founded

1977

Thomson Reuters Corp is listed in the Miscellaneous Publishing sector of the Toronto Stock Exchange with ticker TRI.PR.B. The last closing price for Thomson Reuters was $13.66. Over the last year, Thomson Reuters shares have traded in a share price range of $ 0.00 to $ 0.00.

Thomson Reuters currently has 463,970,000 shares outstanding. The market capitalization of Thomson Reuters is $6.34 billion. Thomson Reuters has a price to earnings ratio (PE ratio) of 28.20.

No news to show yet.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	PR
4	0	0	0	0	0	0	0	PR
12	0	0	0	0	0	0	0	PR
26	0	0	0	0	0	0	0	PR
52	0	0	0	0	0	0	0	PR
156	0	0	0	0	0	0	0	PR
260	0	0	0	0	0	0	0	PR

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
APVOAptevo Therapeutics Inc	$ 0.5092 (52.00%)	234.04M
HUBCWHub Cyber Security Ltd	$ 0.025 (51.52%)	18.16k
SHIMShimmick Corporation	$ 3.13 (51.21%)	31.58M
BANLCBL International Ltd	$ 0.89 (34.85%)	2.99M
WNWMeiwu Technology Company Ltd	$ 1.21 (32.97%)	12.43M
ASLNASLAN Pharmaceuticals Ltd	$ 0.620001 (-44.14%)	1.86M
FDMT4D Molecular Therapeutics Inc	$ 18.26 (-31.74%)	1.87M
SAVACassava Sciences Inc	$ 9.2486 (-31.64%)	11.26M
FIVEFive Below Inc	$ 80.03 (-21.59%)	7.55M
SONMSonim Technologies Inc	$ 0.4117 (-18.65%)	1.75M
APVOAptevo Therapeutics Inc	$ 0.5092 (52.00%)	234.04M
NVDANVIDIA Corporation	$ 119.84 (-5.16%)	169.43M
SQQQProShares UltraPro Short QQQ	$ 7.9701 (6.84%)	87.48M
MAXNMaxeon Solar Technologies Ltd	$ 0.255 (1.03%)	73.14M
VERBVerb Technology Company Inc	$ 0.118 (1.37%)	66.04M

IRisky

IRisky 4 minutes ago

I'm not sure either Cool, but if I was guessing it could be that ZN is "attempting" to conserve money at this time.
Why lease a 20x30 Storage when you can get by with a 10x20.
Maybe ZN found enough Shale Oil in this spot and sees no further need into exploring others.
We have 20

wisetoit

wisetoit 4 minutes ago

Shorts must be panicking

boston745

boston745 4 minutes ago

Theres a gap at 147 to fill too.

crowin

crowin 4 minutes ago

Market Makers Exist

Market Makers Exist 4 minutes ago

PayMEmf

PayMEmf 4 minutes ago

https://m.gsmarena.com/ultrahuman_ring_air_gains_fdaapproved_afib_detection-news-63755.php

Catmandoo

Catmandoo 5 minutes ago

Hilarious, again with the gaylords meeting with each other and guy in black with bun on his head keeps grabbing himself he's so excited, this is the preview for the HAD. Blagmans homerun..lol

Market Makers Exist

Market Makers Exist 5 minutes ago

If you're worried about SS, look at LTCN and SPZI. 5B+ SS both ran over .01+

The only people buying this offering are insiders. Nobody else except OTC traders even know ILST exists.

I've been saying this for a while. This is a long hold.

DNORWOOD

DNORWOOD 5 minutes ago

We are Back Baby. Here we go. Cheers. Too the Moon. Kitty is buying.

Backstabbed

Backstabbed 5 minutes ago

Wouldn’t it have been better to just sell and move on quietly instead of announcing it on FOX News?!?

You just showed your cards!

Sjam410

Sjam410 5 minutes ago

Wondering the same thing. Did something I don't usually do and bought SPX calls for Friday on this dip

Valuestream

Valuestream 5 minutes ago

It's time for a change!--The tide is turning to the upside.

al44

al44 5 minutes ago

Bloodthirsty: Anybody notice how many public 'servants' sided with Trump's would-be assassin?

By Monica Showalter

They're out there. I'm not talking about the mom's basement types who cheered the assassination attempt on President Trump, or Hollywood figures, who went n

BDEZ

BDEZ 5 minutes ago

tmonkey

tmonkey 5 minutes ago

so far doesnt look like the 2 mill is getting dumped down here---not alot of buying either--may need some news to get some traction-------tmonkey

CrashOverride

CrashOverride 5 minutes ago

I am buying more next week. Takes so long for cash to clear on OTC.

We don't need luck. Hang in there longs!

DiscoverGold

DiscoverGold 6 minutes ago

Microsoft (MSFT) Price Prediction and Forecast
By: 24/7 Wall Street | July 17, 2024

Everyone knows Microsoft (NASDAQ: MSFT) and its best known products, including Windows operating system, Microsoft 365 suite of productivity apps but its growing cloud computing platform, A

Viewmont

Viewmont 6 minutes ago

.0014/.0015 around the corner!

$Green$

$Green$ 6 minutes ago

BDEZ

BDEZ 6 minutes ago

Yup for sure…

Whalatane

Whalatane 6 minutes ago

Z. To correct the previous post where I mentioned VERA .
Their LN P 3 trial has been suspended
This suspension follows a previous setback with atacicept in lupus nephritis - the Phase II/III APRIL-LN trial evaluating atacicept in addition to mycophenolate mofetil was prematurely term

dukeb

dukeb 6 minutes ago

An idiot wrote that. Typical Market.live laziness and sloppiness. How about this:

Event Details:

Date/Time: Friday, July 19, 2024
Location: YouTube Theater, Inglewood, Calif.
Hosts: David Meltzer and Dane Cook
Special Guests: Baron Davis, Mars

nathanial

nathanial 7 minutes ago

And no known additional FDA requests from them.....so far....so good.

Thomson Reuters

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions